◆ NeutralKMDA

Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

GlobeNewswire Inc.·
Kamada to Present at the H.C. Wainwright 28th Annual Global Investment Conference

Kamada Ltd., a global biopharmaceutical company specializing in plasma-derived therapies, announced that CEO Amir London will present at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The presentation will be webcast and available for 30 days. The company continues to focus on organic growth of its commercial portfolio, plasma collection operations, and pursuing M&A opportunities.

Read Full Article at GlobeNewswire Inc.
← Back to Financial Intelligence